Introduction
============

In a stereodivergent synthesis \[[@R1]\] often two or more new stereocenters are created with or without control of stereochemistry and it is necessary to identify the configuration of the products. Any diastereomers exhibit disparate NMR spectra, while an experiment employing the nuclear Overhauser effect can often help to assign a particular relative configuration. However, such a task is sometimes impossible due to spectral congestion or lack of diagnostic correlations. On the other hand, the availability of cheap computing power combined with capable software has led to inclusion of computational chemistry into the organic laboratory practice \[[@R2]\]. This provided a powerful tool to augment the interpretation of experimental data including NMR results \[[@R3]--[@R10]\]. Comparisons of experimental and theoretical spectra for the pairs of diastereomers were studied and used quite extensively \[[@R8],[@R10]\].

So far, however, assignments of configuration to four diastereomeric compounds, i.e., tetrads, were mostly performed by separately comparing selected pairs against each other. However, the availability of multiple stereoisomers should translate to more robust assignment when all the data were analyzed at the same time. This is because surplus information should increase the statistical power and therefore improve the confidence in the assignment. This is particularly true since DFT calculated chemical shifts suffer from various systematic errors while the relative differences between the isomers can be predicted quite accurately \[[@R8]\]. Thus, the accuracy should further increase if the results of calculations were referenced to an average of more than two sets of data owing to statistics. Such an approach predating the common use of NMR computation has been applied for comparison of diastereomers against a universal database made of known compounds \[[@R11]--[@R12]\].

Results and Discussion
======================

The idea presented herein is to rank all possible permutations of experimental and computed data rather than focusing on individual pairs. The tetrads need to encompass all stereomers at two selected stereocenters. Thus all possible configurations, e.g., *RR*, *RS*, *SR*, and *SS* need to be distributed to four isomeric compounds. For four different items there are overall *P* ~4~ = 4! = 24 possible permutations. In other words, there are 24 ways in which configurations could be assigned, only one of them correct. The use of permutations ensures that two different diastereomers cannot share the same configuration. Each of these permutations needs to be ranked by how well the experimental and computed data agree. The best match is then expected for a properly assigned configuration, while any swapped configuration should obtain an adequately lower score. The score gap between the best permutation and a second runner-up conveys the confidence in the assignment.

The entire process begins with DFT prediction of isotropic shieldings by one of the established literature procedures, e.g., \[[@R3],[@R9]\], and signal assignment of the experimental NMR spectra. Often, a single ^1^H,^13^C-HSQC experiment was sufficient for complete assignment of ^13^C NMR data. In order to calibrate the data for comparison, for each atom an average (![](Beilstein_J_Org_Chem-13-2478-i007.jpg)) of corresponding chemical shifts in four diastereomers is calculated. Then differences (Δ~i~) between these averages and individual chemical shifts are calculated ([Eq. 1](#FD1){ref-type="disp-formula"}). The same approach is followed for calculated isotropic shieldings. In case of the latter a change of sign is necessary since shieldings are negatively proportional to shifts ([Eq. 2](#FD2){ref-type="disp-formula"}). This way listings of directly comparable Δ~i~ data are created.

![](Beilstein_J_Org_Chem-13-2478-e001.jpg)

![](Beilstein_J_Org_Chem-13-2478-e002.jpg)

Where Δ~i~ is a chemical shift deviation for individual atom/signal, δ~i~ is a measured or calculated chemical shift; ![](Beilstein_J_Org_Chem-13-2478-i008.jpg) is an averaged chemical shift corresponding to an individual atom in all the stereomers; σ~i~ is the isotropic shielding obtained from DFT calculation.

Then, chemical shift listings are arranged into 24 different arrays corresponding to all permutations. For example data of experimental compounds **a**, **b**, **c**, and **d** are arranged to computed data for *RR*, *RS*, *SR*, and *SS* isomers in permutation 1, respectively, *RS*, *RR*, *SR*, and *SS* in permutation 2 and so on (cf. [Table 2](#T2){ref-type="table"}). A comparison is performed between the experimental and computed Δ~i~ data for each of the 24 arrays. There are a few different measures of comparison that can be applied, and some of them are listed in [Table 1](#T1){ref-type="table"}. These can represent difference as mean absolute error (MAE) or related root mean square deviation (RMS). Alternatively, an aggregate overlap of values can be calculated. Also comparison by covariance can be used by means of the Pearson correlation coefficient (R) or similar parameters such as CP1 and CP3 introduced by Smith and Goodman \[[@R8]\]. It has to be noted that for complete sets of Δ~i~ data some of these measures exhibit linear relationship. Finally the permutations are ordered according to their scores from highest to lowest or in the case of mismatch parameters (MAE, RMS) in an inverse order.

###### 

Selected measures of comparison^a^.

  ------- ------------------- --------------------------------------------
  entry   measure             applied formula
                              
  1       MAE                 ![](Beilstein_J_Org_Chem-13-2478-i001.jpg)
  2       RMS                 ![](Beilstein_J_Org_Chem-13-2478-i002.jpg)
  3       aggregate overlap   ![](Beilstein_J_Org_Chem-13-2478-i003.jpg)
  4       R                   ![](Beilstein_J_Org_Chem-13-2478-i004.jpg)
  5       CP1                 ![](Beilstein_J_Org_Chem-13-2478-i005.jpg)
  6       CP3                 ![](Beilstein_J_Org_Chem-13-2478-i006.jpg)
  ------- ------------------- --------------------------------------------

^a^Where Δ~i~ are individual deviations of chemical shifts given in [Eq. 1](#FD1){ref-type="disp-formula"} and [Eq. 2](#FD2){ref-type="disp-formula"} for corresponding atoms, *N* is the total number of signals in all four isomers. For terms with division of by zero in entry 6 assume zero result. Note: when complete sets are studied there is a linear relationship between measures in entries 1 and 3, as well as 4 and 5.

It is noteworthy that after the signal assignment is made, all the steps and numerical operations can be performed with the help of a simple computer program. An example code along with illustration of manual workflow is shown in [Supporting Information File 1](#SD1){ref-type="supplementary-material"}.

Example application
-------------------

In order to exercise the presented approach four (8*R*/*S*,9*R*/*S*) sets of derivatives of *Cinchona* alkaloids **1**--**4** obtained in our laboratory were analyzed ([Fig. 1](#F1){ref-type="fig"}, for references, see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}). The configurations of these derivatives were established based on previous X-ray studies for compounds **2a** and **3d**, NOESY experiments combined with molecular modeling for compounds of type **4**, and chemical correlation for compounds **1a**--**d** (cf. [Scheme 1](#C1){ref-type="fig"}). Also, three sets of matched computed and experimental data for alcohols **5**--**7** were taken directly from the report by Goodman and relevant experimental papers ([Fig. 1](#F1){ref-type="fig"}) \[[@R8],[@R13]--[@R15]\].

![Studied tetrads **1**--**7**.](Beilstein_J_Org_Chem-13-2478-g002){#F1}

Some previously not reported compounds of type **1** and **2** were obtained by epimerization at C9. Mixtures of the isomers of **1** were formed in TBAF desilylation of *Cinchona* 4-TMS-triazole derivatives. Partial isomerisation of **2a** into **2b** was performed by transient deprotonation using in situ generated sodium methylsulfinylmethylide ([Scheme 1](#C1){ref-type="fig"}). Both mixtures of diastereomers were separable by chromatography. However, more than half of **2** was isolated in mixed fractions.

![Synthesis and chemical correlation for compounds of type **1** and **2**.](Beilstein_J_Org_Chem-13-2478-g003){#C1}

The NMR spectra in CDCl~3~ were assigned using ^1^H,^13^C-HSQC and HMBC experiments. For tetrad **4**, NOESY spectra were available and diastereotopic protons were distinguished. Otherwise, the geminal hydrogens were arranged by their chemical shifts. The computed geometries were all optimized at DFT/B3LYP/6-31G(d,p) in vacuum and GIAO calculations were performed at the same level of theory but including polarizable continuum solvent model (PCM) for chloroform utilizing Gaussian code \[[@R16]\]. The initial 6--9 geometries corresponded to rotation along major degrees of freedom, i.e., C4'--C9 and C9--C8 bonds and orientation of the pendant ring. Conformers of up to 3 kcal/mol higher in energy were considered in the calculation and their contribution was included in the Boltzmann-weighted average shieldings ([Eq. 3](#FD3){ref-type="disp-formula"}). The geometries for tetrads **1**--**3** were also reoptimized using the 6-311G+(2d,p) basis set and the GIAO calculation was redone using mPW1PW91 functional and the same basis set as recommended by Tantillo \[[@R3]\]

![](Beilstein_J_Org_Chem-13-2478-e003.jpg)

where *E* ~j~ is the relative energy of conformer *j*, σ*~ij~* is isotropic shielding for atom *i* in conformer *j*.

An example of scoring of all permutations based on ^13^C NMR data for tetrad **1** is shown in [Table 2](#T2){ref-type="table"} (for all data, see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}).

###### 

Permutation scores for the comparison of experimental ^13^C NMR chemical shifts deviations and DFT isotropic shieldings.^a^

  -------- --------------- ----------- ----------- ----------- -------- --------- ------ -------
  entry    configuration   score^b^                                                      
                                                                                         
  **1a**   **1b**          **1c**      **1d**      R           CP3      overlap   RMS    
                                                                                         
  1^c^     8*S*,9*S*       8*S*,9*R*   8*R*,9*R*   8*R*,9*S*   0.881    0.682     44.7   0.728
  2        8*S*,9*S*       8*S*,9*R*   8*R*,9*S*   8*R*,9*R*   0.842    0.662     42.0   0.830
  3        8*S*,9*R*       8*S*,9*S*   8*R*,9*R*   8*R*,9*S*   0.835    0.654     40.3   0.846
  4        8*S*,9*R*       8*S*,9*S*   8*R*,9*S*   8*R*,9*R*   0.796    0.634     37.6   0.936
  5        8*S*,9*S*       8*R*,9*S*   8*R*,9*R*   8*S*,9*R*   0.169    0.042     28.2   1.853
  6        8*S*,9*S*       8*R*,9*R*   8*R*,9*S*   8*S*,9*R*   0.113    0.022     26.6   1.913
  7        8*S*,9*R*       8*R*,9*S*   8*R*,9*R*   8*S*,9*S*   0.097    0.003     23.9   1.930
  8        8*R*,9*S*       8*S*,9*S*   8*R*,9*R*   8*S*,9*R*   0.077    −0.056    22.8   1.951
  9        8*R*,9*R*       8*S*,9*S*   8*R*,9*S*   8*S*,9*R*   0.059    −0.046    25.0   1.970
  10       8*R*,9*S*       8*S*,9*R*   8*R*,9*R*   8*S*,9*S*   0.051    −0.067    22.9   1.978
  11       8*S*,9*R*       8*R*,9*R*   8*R*,9*S*   8*S*,9*S*   0.042    −0.017    22.4   1.988
  12       8*R*,9*R*       8*S*,9*R*   8*R*,9*S*   8*S*,9*S*   0.033    −0.057    25.1   1.997
  13       8*S*,9*S*       8*R*,9*S*   8*S*,9*R*   8*R*,9*R*   −0.026   −0.266    23.4   2.057
  14       8*S*,9*S*       8*R*,9*R*   8*S*,9*R*   8*R*,9*S*   −0.043   −0.267    24.5   2.073
  15       8*S*,9*R*       8*R*,9*S*   8*S*,9*S*   8*R*,9*R*   −0.068   −0.277    21.1   2.097
  16       8*S*,9*R*       8*R*,9*R*   8*S*,9*S*   8*R*,9*S*   −0.084   −0.277    22.2   2.113
  17       8*R*,9*R*       8*S*,9*R*   8*S*,9*S*   8*R*,9*S*   −0.093   −0.317    24.9   2.122
  18       8*R*,9*R*       8*S*,9*S*   8*S*,9*R*   8*R*,9*S*   −0.097   −0.335    22.9   2.126
  19       8*R*,9*S*       8*S*,9*R*   8*S*,9*S*   8*R*,9*R*   −0.114   −0.346    20.1   2.142
  20       8*R*,9*S*       8*S*,9*S*   8*S*,9*R*   8*R*,9*R*   −0.118   −0.364    18.0   2.146
  21       8*R*,9*R*       8*R*,9*S*   8*S*,9*S*   8*S*,9*R*   −0.805   −0.957    8.5    2.721
  22       8*R*,9*R*       8*R*,9*S*   8*S*,9*R*   8*S*,9*S*   −0.835   −0.986    6.5    2.744
  23       8*R*,9*S*       8*R*,9*R*   8*S*,9*S*   8*S*,9*R*   −0.842   −0.986    4.7    2.749
  24       8*R*,9*S*       8*R*,9*R*   8*S*,9*R*   8*S*,9*S*   −0.873   −1.015    2.8    2.772
  -------- --------------- ----------- ----------- ----------- -------- --------- ------ -------

^a^Permutations arranged by the value of Pearson correlation coefficient. ^b^Scores (cf. [Table 1](#T1){ref-type="table"}): R -- Pearson correlation coefficient; CP3 -- Smith and Goodman's comparison parameter; overlap -- aggregate overlap of datasets; RMS -- root mean square difference. ^c^Correct assignment of configuration. For ^1^H NMR comparison table and for similar tables for compounds **2**--**7**, see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}.

For all the compounds comparison of the ^13^C NMR data identified the permutations corresponding to proper configuration assignment with the highest scores ([Table 3](#T3){ref-type="table"}). This was found regardless of the measure used for comparison. The separation between the scores for the correct assignment and a following best permutation varied widely for different tetrads **1**--**7**. However, the separation was generally larger for sets where better agreement for the correct assignment was found. On the other hand, for two of the tested tetrads, namely **3** and **7**, the comparison of ^1^H NMR data did not identify the correct assignment with the highest score. The incorrect ^1^H assignments were characterized by relatively low values of highest correlation coefficients (0.71 and 0.47) compared to the coefficients (0.71--0.95) for properly identified tetrads **1**, **4**, **5**, and **6**. The order of lower ranking permutations was vastly different between ^1^H and ^13^C data. This indicates that both nuclei can be used for independent assignment of configuration. It has to be emphasized that the ^1^H NMR data for tetrads **1** and **4** were very predictive of configuration, as demonstrated by higher correlation coefficients than for ^13^C NMR data. These two compounds are less likely to form hydrogen bonds and specific interactions with the solvent, therefore their conformational equilibria are more likely to be accurately modeled by DFT calculation.

###### 

Permutations with two highest scores for the comparison of experimental ^13^C NMR chemical shifts deviations and DFT isotropic shieldings.

  ------- --------------- ----------- ----------- ----------- ------- ---------- --------- -------
  entry   configuration   score                                                            
                                                                                           
                                                              R       CP3        overlap   RMS
                                                                                           
          **1a**          **1b**      **1c**      **1d**                                   
  1^a^    8*S*,9*S*       8*S*,9*R*   8*R*,9*R*   8*R*,9*S*   0.881   0.682      44.7      0.728
  2       8*S*,9*S*       8*S*,9*R*   8*R*,9*S*   8*R*,9*R*   0.842   0.662      42.0      0.830
          **2a**          **2b**      **2c**      **2d**                                   
  3^a^    8*S*,9*S*       8*S*,9*R*   8*R*,9*R*   8*R*,9*S*   0.969   0.935      52.8      0.330
  4       8*S*,9*S*       8*S*,9*R*   8*R*,9*S*   8*R*,9*R*   0.925   0.894      47.5      0.512
          **3a**          **3b**      **3c**      **3d**                                   
  5^a^    8*S*,9*S*       8*S*,9*R*   8*R*,9*R*   8*R*,9*S*   0.895   0.781      64.1      0.719
  6       8*S*,9*S*       8*S*,9*R*   8*R*,9*S*   8*R*,9*R*   0.726   0.599^b^   51.8      1.111
          **4a**          **4b**      **4c**      **4d**                                   
  7^a^    8*S*,9*S*       8*S*,9*R*   8*R*,9*R*   8*R*,9*S*   0.960   0.912      61.5      0.411
  8       8*S*,9*S*       8*S*,9*R*   8*R*,9*S*   8*R*,9*R*   0.677   0.613      48.2      1.161
          **5a**          **5b**      **5c**      **5d**                                   
  9^a^    1*S*,3*R*       1*R*,3*R*   1*S*,3*S*   1*R*,3*S*   0.920   0.769      30.4      0.732
  10      1*S*,3*R*       1*R*,3*S*   1*S*,3*S*   1*R*,3*R*   0.626   0.538      22.0      1.515
          **6a**          **6b**      **6c**      **6d**                                   
  11^a^   2*R*,4*R*       2*S*,4*R*   2*S*,4*S*   2*R*,4*S*   0.657   0.479      23.3      1.193
  12      2*R*,4*R*       2*S*,4*S*   2*S*,4*R*   2*R*,4*S*   0.424   0.297      21.1      1.517
          **7a**          **7b**      **7c**      **7d**                                   
  13^a^   3*R*,5*R*       3*R*,5*S*   3*S*,5*S*   3*S*,5*R*   0.842   0.623      29.5      0.599
  14      3*R*,5*R*       3*S*,5*S*   3*R*,5*S*   3*S*,5*R*   0.774   0.536      26.9      0.715
  ------- --------------- ----------- ----------- ----------- ------- ---------- --------- -------

^a^Correct assignment of configuration ^b^For this parameter a different second highest scoring permutation exists. For the details, see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}.

Reinforcing computational methods by extending the basis set to 6-311G++(2d,2p) for both optimization and NMR calculation steps, as well as applying the MPW1PW91 functional (compounds **1**--**3**) did not affect the comparison significantly. However, most of the comparison parameters for ^13^C NMR data were improved for the correct permutation. Also the separations between the scores for correct assignment and second best permutation were slightly increased according to the majority of measures.

One compound missing
--------------------

In order to address the scenario when not all diastereomers are available, for example due to inherent instability of one of them, an incomplete comparison was performed. For this purpose sets of experimental shifts for only three compounds were matched against four listings of DFT-derived data. All possible sets for compounds **1**--**7** were analyzed. It was then checked whether the highest ranked permutations corresponded to the correct assignment. It was found that in most cases the ^13^C NMR data correctly identified the proper configuration of the diastereomers. Unfortunately in this scenario the application of ^1^H NMR data would lead to a few incorrect assignments. The choice of comparison measures affected the result noticeably ([Table 4](#T4){ref-type="table"}). The lack of a fourth experimental data set introduces a bias in the average of experimental shifts. This particularly affects measures which overemphasize differences (such as CP3). On the other hand RMS deviation and Pearson correlation coefficient proved as the most effective scores. While assignment for the three out of four diastereomers was found to be mostly accurate, synthesis and inclusion of a "missing" isomer would noticeably improve the chance for a correct assignment (100% vs 92% for ^13^C, and 77% vs 62% for ^1^H) for the studied tetrads **1**--**7**.

###### 

Percentage of correctly identified configuration by highest ranking permutation for sets of three out of four diastereomers of compounds **1**--**7**.

  ------------- ---------------- ---------------
  measure       ^13^C NMR data   ^1^H NMR data
                                 
  CP1           96%              46%
  CP2           79%              67%
  CP3           89%              58%
  overlap       89%              67%
  RMS           100%             67%
  correlation   100%             63%
  MAE           96%              67%
  ------------- ---------------- ---------------

Conclusion
==========

The presented approach using ^13^C NMR data led to a correct assignment of configuration to the sets of four or three diastereomers, alleviating the need for scaling of chemical shifts. By feeding all available NMR data into the algorithm a permutation with a highest rank is identified. The major limitation is how accurately the experiment is predicted by the DFT calculation. This is, however, a central problem and any data processing will fail in cases where the computed data do not agree with the experiment.

Experimental
============

**9** ***R*** **-(4-Trimethylsilyl-1,2,3-triazol-1-yl)-9-deoxyquinidine:** To a solution of 9*R*-azido-9-deoxyquinidine (969 mg, 2.78 mmol) in a mixture of *tert*-butanol (18 mL) and water (9 mL) were added trimethylsilylacetylene (0.5 mL, 3.5 mmol, 1.3 equiv), CuSO~4~·5H~2~O (22 mg, 3 mol %), and sodium ascorbate (157 mg, 29 mol %). The mixture was stirred for 24 h, then a drop of saturated aqueous Na~2~S was added and the mixture was extracted with CH~2~Cl~2~, dried over MgSO~4~ and filtered through a pad (2 cm) of silica gel and evaporated. Evacuation on a rotary vane pump afforded 978 mg of the product with 10 mol % of residual *tert*-butanol as amorphous white solid (78%). ^1^H NMR (600 MHz, CDCl~3~) δ 8.76 (d, *J* = 4.6 Hz, 1H), 8.00 (d, *J* = 9.2 Hz, 1H), 7.54 (d, *J* = 4.6 Hz, 1H), 7.47 (d, *J* = 2.4 Hz, 1H), 7.47 (s, 1H), 7.37 (dd, *J* = 9.2, 2.4 Hz, 1H), 6.45 (br., 1H), 5.82 (ddd, *J* = 17.1, 10.6, 6.5 Hz 1H), 5.07 (d, *J* = 17.1 Hz, 1H), 5.05 (d, *J* = 10.6 Hz, 1H), 4.02--3.97 (m, 1H), 3.94 (s, 3H), 3.02--2.96 (m, 3H), 2.90--2.84 (m, 1H), 2.29--2.24 (m, 1H), 1.72--1.71 (m, 1H), 1.67--1.56 (m, 2H), 1.38--1.33 (m, 1H), 1.23--1.27 (s, 1H), 0.21 (s, 9H) ppm; ^13^C NMR (151 MHz, CDCl~3~) δ 158.7, 147.5, 146.3, 145.0, 140.39, 140.36, 132.1, 128.10, 128.00, 122.5, 119.9, 115.0, 100.7, 59.2 (br.), 58.4, 55.8, 49.4, 47.6, 39.2, 27.8, 26.5, 26.0, −1.0 ppm. HRMS--ESI--TOF (*m*/*z*): \[M + H\]^+^ calcd for C~25~H~34~N~5~OSi, 448.2527; found, 448.2521.

**9** ***S-*** **and 9** ***R*** **-(1,2,3-triazol-1-yl)-9-deoxyquinidine (1d and 1c):** 9*R*-(4-Trimethylsilyl-1,2,3-triazol-1-yl)-9-deoxyquinidine (329 mg, 0.77 mmol) was dissolved in THF (10 mL), then a solution of TBAF (1.1 mL, 1 M in THF, 1.4 equiv) was added, and the mixture was stirred at 60 °C for 28 h and evaporated. HRMS--ESI--TOF (*m*/*z*): \[M + H\]^+^ calcd for C~22~H~24~N~5~O, 376.2132; found, 376.2126. Chromatography on silica gel (CHCl~3~/MeOH, 20:1) afforded 128 mg of **1d** (46%), and 61 mg of **1c** (22%) as white amorphous solids.

**1c**: ^1^H NMR (600 MHz, CDCl~3~) δ 8.78 (d, *J* = 4.6 Hz, 1H), 8.02 (d, *J* = 9.2 Hz, 1H), 7.62 (s, 1H), 7.56 (s, 1H), 7.53 (d, *J* = 4.6 Hz, 1H), 7.47 (d, *J* = 2.6 Hz, 1H), 7.38 (dd, *J* = 9.2, 2.6 Hz, 1H), 6.51(d, *J* = 10.7 Hz, 1H), 5.85 (ddd, *J* = 17.1, 10.6, 6.5 Hz, 1H), 5.12 (dt, *J* = 17.1, 1.3 Hz, 1H), 5.09 (dt, *J* = 10.6, 1.4 Hz, 1H), 3.95 (s, 1H), 3.96--3.91 (m, 1H), 3.10--3.05 (m, 1H), 3.01--2.96 (m, 2H), 2.93--2.87 (m, 1H), 2.32--2.27 (m, 1H), 1.77--1.74 (m, 1H), 1.69--1.60 (m, 2H), 1.46--1.41 (m, 1H), 1.31--1.27 (m, 1H) ppm; ^13^C NMR (151 MHz, CDCl~3~) δ 158.7, 147.4, 145.0, 140.2, 139.7, 133.8, 132.1, 128.1, 122.5 (2C overlapped), 119.5, 115.0, 100.5, 59.6, 58.3, 55.8, 49.4, 47.2, 39.0, 27.6, 26.5, 26.2 ppm.

**1d**: ^1^H NMR (600 MHz, CDCl~3~) δ 8.82 (d, *J* = 4.6 Hz, 1H), 7.98 (d, *J* = 9.2 Hz, 1H), 7.63 (br., 1H), 7.59 (s, 1H), 7.34--7.29 (m, 3H), 6.45 (br. d, *J* = 10.4 Hz, 1H), 6.01 (ddd, *J* = 17.3, 10.4, 7.3 Hz, 1H), 5.12 (d, *J* = 10.4 Hz, 1H), 5.08 (d, *J* = 17.2 Hz, 1H), 3.88 (s, 3H), 3.90--3.86 (m, 1H), 3.09--3.04 (m, 1H), 2.92--2.82 (m, 2H), 2.73--2.68 (m, 1H), 2.31--2.26 (m, 1H), 1.82--1.79 (m, 1H), 1.70--1.61 (m, 3H), 1.21--1.15 (m, 1H) ppm. ^13^C NMR (151 MHz, CDCl~3~) *δ*: 158.5, 147.6, 145.1, 140.06, 140.02, 134.4, 132.1, 128.1, 122.46, 122.21, 119.7, 115.3, 100.5, 60.8, 57.5, 55.9, 49.3, 48.3, 39.8, 27.5, 26.4, 24.7 ppm.

**9** ***R*** **-(1,2,3-Triazol-1-yl)-9-deoxyquinine** (**1b**) was prepared analogously to **1d**: Starting from 1.81 g of 9*S*-(4-trimethylsilyl-1,2,3-triazol-1-yl)-9-deoxyquinine, 600 mg of pure **1b** (40%) and 542 mg (36%) of **1a** were obtained. Alternatively starting from 272 mg of 9*R*-(4-trimethylsilyl-1,2,3-triazol-1-yl)-9-deoxyquinine 97 mg of **1b** (42%) and 88 mg of **1a** (39%) were obtained both as amorphous solids. *R* ~f~ (CHCl~3~:MeOH, 20:1): 0.34 for **1a**, 0.42 for **1b**.

**1b**: ^1^H NMR (600 MHz, CDCl~3~) δ 8.83 (d, *J* = 4.6 Hz, 1H), 7.99 (d, *J* = 9.2 Hz, 1H), 7.70 (d, *J* =4.6 Hz, 1H), 7.60 (s, 1H), 7.36 (d, *J* = 2.6 Hz, 1H), 7.31 (s, 1H), 7.30 (dd, *J* = 9.2, 2.6 Hz), 6.45 (d, *J* = 11.3 Hz, 1H), 5.89 (ddd, *J* = 17.3, 10.4, 7.3 Hz, 1H), 5.07 (dt, *J* = 17.3, 1.3 Hz, 1H), 5.05 (dt, *J* = 10.4, 1.4 Hz, 1H), 3.88 (s, 3H), 3.95--3.83 (m, 1H), 3.16 (dd, *J* = 13.6, 10.0 Hz, 1H), 2.93--2.84 (m, 2H), 2.66--2.60 (m, 1H), 2.35--2.29 (m, 1H), 1.85--1.82 (m, 1H), 1.77--1.72 (m, 1H), 1.57--1.52 (m, 2H), 1.37--1.33 (m, 1H) ppm; ^13^C NMR (151 MHz, CDCl~3~) δ 158.6, 147.6, 145.1, 141.7, 139.6, 134.6, 132.1, 128.0, 122.25, 122.20, 119.9, 114.9, 100.4, 61.4, 57.4, 56.0, 55.8, 41.5, 39.5, 27.7, 27.2, 25.2 ppm; HRMS--ESI--TOF (*m*/*z*): \[M + H\]^+^ calcd for C~22~H~26~N~5~O, 376.2132; found, 376.2141.

**9** ***R*** **-Phenyl-9-deoxyquinine (2b):** Under inert gas (Ar), a sodium hydride dispersion (60% in mineral oil, 195 mg, 4.9 mmol, 5 equiv) was dissolved in DMSO (9 mL) over 1.5 h at 65 °C and cooled to room temperature. Then a solution of 9*S*-deoxy-9-phenylquinine (**2a**, 395 mg, 1.03 mmol) in DMSO (1.8 mL) was added and the mixture stirred for 25 min. Then ice was added and the mixture diluted with Et~2~O (20 mL), and washed with brine (5 × 25 mL), dried over Na~2~SO~4~ and evaporated to give 322 mg of a **2a**:**2b** mixture, 38:62 by ^1^H NMR integration. Careful separation by chromatography (AcOEt/MTBE/MeOH, 10:10:1) gave 45 mg of pure **2b** (11%) as an off-white amorphous solid, the remaining **2b** was received in a mixture with **2a**. ^1^H NMR (300 MHz, CDCl~3~) δ 8.80 (d, *J* = 4.6 Hz, 1H), 7.96 (d, *J* = 9.2 Hz, 1H), 7.57 (d, *J* = 4.6 Hz, 1H), 7.42 (d, *J* = 2.6 Hz, 1H), 7.34 (d, *J* = 8.2 Hz, 2H), 7.27 (dd, *J* = 9.2, 2.6 Hz, 1H), 7.24 (t, *J* = 8.0 Hz, 2H), 7.13 (tt, *J* = 7.6, 1.3 Hz, 1H), 5.92 (ddd, *J* = 17.4, 10.2, 7.4 Hz,1H), 5.09--5.00 (m, 2H), 4.63 (d, *J* = 11.3 Hz, 1H), 3.90 (s, 3H), 3.73--3.63 (m, 1H), 3.19 (dd, *J* = 13.7, 9.9 Hz, 1H), 2.99--2.89 (m, 1H), 2.80--2.88 (m, 1H), 2.61--2.50 (m, 1H), 2.33--2.22 (m, 1H), 1.79--1.76 (m, 1H), 1.72--1.43 (m, 4H), 1.29--1.21 (m, 1H) ppm; ^13^C NMR (75.5 MHz, CDCl~3~) δ 157.5, 147.8, 146.9, 144.9, 142.1, 140.7, 131.9, 129.0, 128.6, 128.4, 126.9, 120.5, 119.7, 114.7, 102.0, 58.3, 56.2, 55.5, 50.2, 41.0, 39.8, 28.1, 28.0, 27.9 ppm.
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